PLAT anticorps

N° du produit ABIN7536741

Cet anticorps anti-PLAT est un anticorps Mouton Polyclonal détectant PLAT dans WB, ELISA, IP, IEP, IDe et Neut. Adapté pour Humain.

Aperçu rapide pour PLAT anticorps (ABIN7536741)

Antigène: PLAT (Plasminogen Activator, Tissue (PLAT))

Reactivité: Humain

Hôte: Mouton

Clonalité: Polyclonal

Conjugué: Cet anticorp PLAT est non-conjugé

Application: Western Blotting (WB), ELISA, Immunoprecipitation (IP), Immunoelectrophoresis (IEP), Immunodepletion (IDe), Neutralization (Neut)

Détail du produit anti-PLAT anticorps

Fonction: tPA - tissue plasminogen activator Polyclonal Antibody

Specificité: Human Tissue-type Plasminogen Activator, tPA

Purification: Fractionation of IgG from antiserum

Immunogène: Human tissue-type plasminogen activator (tPA) prepared from melanoma cell line

Isotype: IgG

Information d'application

Indications d'application: Immunoblot 5-25 μg/mL, ELISA capture 20-50 μg/mL

Commentaires:

Whole IgG is a base level product and refers to IgG antibodies purified from antiserum using multiple precipitation and dialysis steps. The purity of the IgG is typically 90% and is provided in a solution of HEPES buffered saline containing 50% glycerol (v/v). The titre is essentially the same as the starting antiserum and each vial typically contains the amount of IgG recovered from one millilitre of antiserum. This level of product is generally intended for use in applications such as immunoprecipitation, immunoelectrophoresis, immuno-depletion and activity neutralization assays.

Restrictions: For Research Use only

Stockage

Format: Liquid

Reconstitution: Allow product to warm to room temperature and gently mix before use

Concentration: 10 mg/mL

Buffer: 10 mM HEPES, pH 7.4, 150 mM NaC, 50 % (v/v) glycerol

Stock: -20 °C

Stockage commentaire: Store between -10°C and -20°C

Détails sur PLAT

Antigène: PLAT (Plasminogen Activator, Tissue (PLAT))

Autre désignation: tPA

Pathways: Autophagy, Smooth Muscle Cell Migration, Platelet-derived growth Factor Receptor Signaling, SARS-CoV-2 Protein Interactome